Gilman Hill Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Gilman Hill Asset Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,509	Closed	-$355K	–	182
2016 Q4	$355K	Hold	4,509	–	–	0.13%	128
2016 Q3	$352K	Hold	4,509	–	–	0.14%	123
2016 Q2	$310K	Hold	4,509	–	–	0.13%	127
2016 Q1	$322K	Sell	4,509 -1,544	-26%	-$96.9K	0.15%	123
2015 Q4	$376K	Sell	6,053 -227	-4%	-$13.8K	0.18%	108
2015 Q3	$356K	Buy	6,280 +62	+1%	+$3.28K	0.19%	99
2015 Q2	$334K	Hold	6,218	–	–	0.16%	117
2015 Q1	$295K	Buy	6,218 +628	+11%	+$27.8K	0.14%	119
2014 Q4	$242K	Sell	5,590 -371	-6%	-$15.2K	0.12%	132
2014 Q3	$205K	Sell	5,961 -2,023	-25%	-$71.4K	0.11%	146
2014 Q2	$292K	Sell	7,984 -280	-3%	-$9.5K	0.15%	117
2014 Q1	$279K	Hold	8,264	–	–	0.16%	105
2013 Q4	$280K	Hold	8,264	–	–	0.18%	91
2013 Q3	$263K	Sell	8,264 -2,353	-22%	-$62.6K	0.19%	84
2013 Q2	$240K	Buy	+10,617	New	+$230K	0.17%	91

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Gilman Hill Asset Management's CMD Position: Q1 2017 in Review

Gilman Hill Asset Management sold out of Cantel Medical Corporation (CMD) in Q1 2017, closing a stake of 4,509 shares — an estimated $355K sold.

Gilman Hill Asset Management first reported a position in CMD in Q2 2013 and held it in 15 quarters. The position peaked at $376K in Q4 2015. 218 funds tracked by Wall St. Rank hold CMD as of Q1 2017.

Gilman Hill Asset Management reported no remaining Cantel Medical Corporation position as of Q1 2017 after selling out during the quarter.
Gilman Hill Asset Management sold 4,509 Cantel Medical Corporation shares in Q1 2017, an estimated $355K.
Gilman Hill Asset Management first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 15 quarters.
Gilman Hill Asset Management's Cantel Medical Corporation position peaked at $376K in Q4 2015.
218 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2017.

Based on Gilman Hill Asset Management's 13F filing for Q1 2017, filed 24 Apr 2017.